Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Relative effectiveness and the European pharmaceutical market.

× No keyword cloud information.

9 in total

1. Lack of support for cost-utility analysis in the health care reform law: a case of ignorance or political posturing?

Authors: James W Shaw
Journal: Clin Ther Date: 2010-06 Impact factor: 3.393

2. A French approach to cost-effectiveness analysis?

Authors: Gérard de Pouvourville
Journal: Eur J Health Econ Date: 2010-12

3. Comparative effectiveness research: Policy context, methods development and research infrastructure.

Authors: Sean R Tunis; Joshua Benner; Mark McClellan
Journal: Stat Med Date: 2010-08-30 Impact factor: 2.373

4. Legislating against use of cost-effectiveness information.

Authors: Peter J Neumann; Milton C Weinstein
Journal: N Engl J Med Date: 2010-10-14 Impact factor: 91.245

5. A global comparison regarding patient access to cancer drugs.

Authors: B Jönsson; N Wilking
Journal: Ann Oncol Date: 2007-04 Impact factor: 32.976

6. Health technology assessment: regulators or payers--who will take the lead?

Authors: Bengt Jönsson
Journal: Clin Ther Date: 2008-05 Impact factor: 3.393

Review 7. Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers.

Authors: Hans-Georg Eichler; Brigitte Bloechl-Daum; Eric Abadie; David Barnett; Franz König; Steven Pearson
Journal: Nat Rev Drug Discov Date: 2010-02-26 Impact factor: 84.694

Review 8. Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers.

Authors: Josh J Carlson; Sean D Sullivan; Louis P Garrison; Peter J Neumann; David L Veenstra
Journal: Health Policy Date: 2010-03-11 Impact factor: 2.980

9. Reimbursement of pharmaceuticals: reference pricing versus health technology assessment.

Authors: Michael Drummond; Bengt Jönsson; Frans Rutten; Tom Stargardt
Journal: Eur J Health Econ Date: 2010-08-28

9 in total

6 in total

1. Relative efficacy and effectiveness assessment of new pharmaceuticals in three EU member states: current practices and outcome agreement between Belgium, the Netherlands and France.

Authors: P B Van Wilder; V V Bormans; A G Dupont
Journal: Eur J Clin Pharmacol Date: 2013-09-01 Impact factor: 2.953

Review 6. Improving Interactions Between Health Technology Assessment Bodies and Regulatory Agencies: A Systematic Review and Cross-Sectional Survey on Processes, Progress, Outcomes, and Challenges.

Authors: Richard Ofori-Asenso; Christine E Hallgreen; Marie Louise De Bruin
Journal: Front Med (Lausanne) Date: 2020-10-16